Torrent Pharmaceuticals (India) Top Insiders
TORNTPHARM | 3,521 16.80 0.48% |
Torrent Pharmaceuticals employs about 12 people. The company is managed by 12 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Assessment of Torrent Pharmaceuticals' management performance can provide insight into the firm performance.
Sanjay Gupta President President USA |
Torrent |
Torrent Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of 0.1217 % which means that it generated a profit of $0.1217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2646 %, meaning that it generated $0.2646 on every $100 dollars invested by stockholders. Torrent Pharmaceuticals' management efficiency ratios could be used to measure how well Torrent Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Torrent Pharmaceuticals' Other Current Assets are increasing as compared to previous years. The Torrent Pharmaceuticals' current Net Tangible Assets is estimated to increase to about 20.3 B, while Total Assets are projected to decrease to under 85.8 B.The current Common Stock Shares Outstanding is estimated to decrease to about 270.8 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 12 B
Torrent Pharmaceuticals Workforce Comparison
Torrent Pharmaceuticals Limited is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 46,006. Torrent Pharmaceuticals adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Torrent Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Torrent Pharmaceuticals Price Series Summation is a cross summation of Torrent Pharmaceuticals price series and its benchmark/peer.
Torrent Pharmaceuticals Notable Stakeholders
A Torrent Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Torrent Pharmaceuticals often face trade-offs trying to please all of them. Torrent Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Torrent Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sanjay Gupta | President USA | Profile | |
CWA CA | Executive CFO | Profile | |
Aman Mehta | WholeTime Director | Profile | |
Ashish MPharm | Executive Director | Profile | |
MMS BE | VP Projects | Profile | |
Chandrashekhar CA | VP Procurement | Profile | |
Jaydip Bhatt | Vice Resource | Profile | |
Samir Mehta | Ex MD | Profile | |
Kaushal CA | Vice Finance | Profile | |
Chintan Trivedi | Company Officer | Profile | |
MPha BPharm | Vice Works | Profile | |
Abdullah Abri | Chief Officer | Profile |
About Torrent Pharmaceuticals Management Performance
The success or failure of an entity such as Torrent Pharmaceuticals often depends on how effective the management is. Torrent Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Torrent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Torrent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Torrent Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.
Torrent Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Torrent Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Torrent Pharmaceuticals within its industry.Torrent Pharmaceuticals Manpower Efficiency
Return on Torrent Pharmaceuticals Manpower
Revenue Per Employee | 9.6B | |
Revenue Per Executive | 9.6B | |
Net Income Per Employee | 1.6B | |
Net Income Per Executive | 1.6B | |
Working Capital Per Employee | 755M | |
Working Capital Per Executive | 755M |
Complementary Tools for Torrent Stock analysis
When running Torrent Pharmaceuticals' price analysis, check to measure Torrent Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Torrent Pharmaceuticals is operating at the current time. Most of Torrent Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Torrent Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Torrent Pharmaceuticals' price. Additionally, you may evaluate how the addition of Torrent Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |